论文部分内容阅读
再障的发病机理目前尚未完全阐明,用同种骨髓移植能重建患者的造血功能提示了造血干细胞的受损可能是本病的主要发病机制之一,但骨髓移植由于受多种条件的限制,目前在国内尚难广泛开展。近年来国内外相继用胎肝细胞输注(FLT)治疗再障,并取得一定疗效。我们在1982年曾用胎肝细胞悬液短期内多次输注治愈1例重症再障,从中得到启发,自1981年3月至1983年7月,我们连续治疗再障15例共63次,取得较好
The pathogenesis of aplastic anemia has not yet been fully elucidated, with allogeneic bone marrow transplantation can reconstruct the patient’s hematopoietic function prompted the damage of hematopoietic stem cells may be one of the main pathogenesis of the disease, but due to a variety of bone marrow transplantation restrictions, At present it is difficult to carry out extensively in China. In recent years, both at home and abroad with fetal liver infusion (FLT) treatment of aplastic anemia, and achieved a certain effect. In 1982, we used fetal liver cell suspension in a short period of multiple transfusions to cure one case of severe aplastic anemia, which inspired us from March 1981 to July 1983, we continued treatment of aplastic anemia in 15 cases a total of 63 times, Get better